Singapore legislation

Clause 66

Related amendment to Health Products Act

Paragraph 1 of the Second Schedule to the Health Products Act (Cap. 122D, 2008 Ed.) is amended by deleting sub-paragraph (i) and substituting the following sub-paragraph:“(i)for regulating the conduct of clinical trials of health products, and prescribing the matters relating to any consent for a subject to participate in such a trial, including —

(i)

the persons who may so consent;

(ii)

the considerations which any such person must take into account before so consenting;

(iii)

the circumstances in which the consent of such person may be relied upon; and

(iv)

the circumstances in which no consent of any person is required for the subject’s participation in the trial,and whether any matter so prescribed has effect in addition to or despite any other written law or rule of law;”.

Read in full context — Human Biomedical Research Bill →